MSB 3.21% $1.13 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-802

  1. 338 Posts.
    lightbulb Created with Sketch. 3
    Does anyone know the time frame for the next stage of testing?

    Thanks
    Alf
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.